Slabicap, drops 7.5 mg/ml 10 ml

Laxacap is a laxative.

It reduces absorption of electrolytes and water, increases intestinal peristalsis.

The active form of the drug, formed by hydrolysis under the influence of intestinal microorganisms, directly excites the nervous structures of the intestinal wall, resulting in acceleration of movement of the intestinal contents.

The action occurs 10 – 12 hours after intake.

Pharmacokinetics

After oral administration, it is not absorbed from the gastrointestinal tract and is not subject to hepatic circulation.

Indications

Atonic constipation.
Regulation of stool (hemorrhoids, proctitis, anal fissures).
Preparation for surgical operations, instrumental and x-ray examinations.

Pharmacological effect

Slabicap is a laxative.

Reduces the absorption of electrolytes and water, enhances intestinal motility.

The active form of the drug, formed by hydrolysis under the influence of intestinal microorganisms, directly stimulates the nervous structures of the intestinal wall, resulting in accelerated movement of intestinal contents.

The effect occurs 10 – 12 hours after administration.

Pharmacokinetics

After oral administration, it is not absorbed from the gastrointestinal tract and does not undergo hepatic-intestinal circulation.

Special instructions

It has no taste, so it can be added to children’s food.

In children it should be used only as prescribed by a doctor.

Do not use daily without medical supervision for more than 10 days.

Active ingredient

Sodium picosulfate

Composition

100 ml. drops for oral administration contain:

active ingredients:

sodium picosulfate in terms of anhydrous – 750 mg,

excipients:

sorbitol (sorbitol),

propylene glycol,

water for injection – up to 100 ml

Contraindications

Hypersensitivity,
intestinal obstruction,
strangulated hernia,
acute inflammatory diseases of the abdominal organs.
peritonitis,
abdominal pain (of unknown origin),
severe dehydration,
bleeding from the gastrointestinal tract,
metrorrhagia,
cystitis,
spastic constipation,
children’s age (up to 4 years),
pregnancy (first trimester).

With caution: lactation period.

Side Effects

Diarrhea,
stomach pain,
dehydration,
disturbances in water and electrolyte balance,
weakness,
convulsions,
decrease in blood pressure.

Interaction

Possible increased sensitivity to cardiac glycosides.

GCS and diuretics when used simultaneously with Slabicap increase the risk of developing electrolyte disturbances.

Broad-spectrum antibiotics reduce the laxative effect of Slabicap.

Overdose

Symptoms: possible increased side effects. In addition, with chronic overdose, ischemia of the colon mucosa, secondary hyperaldosteronism, urolithiasis, and damage to the renal tubules may develop.

Treatment: gastric lavage, correction of water-electrolyte balance disorders, antispasmodics are prescribed.

Storage conditions

In a place protected from light, at temperatures below 20 °C

Shelf life

2 years

Manufacturer

Sintez, Russia